Eam Global Investors LLC Vericel Corp Transaction History

Eam Global Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$47.2 - $67.81 $2.3 Million - $3.31 Million	-48,797 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$30.93 - $59.48 $2.85 Million - $5.49 Million	-92,265 Reduced 65.41%	48,797 $2.71 Million
Q4 2020 Feb 11, 2021	BUY	$18.53 - $31.5 $2.61 Million - $4.44 Million	141,062 New	141,062 $4.36 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $1.39 Million - $1.75 Million	-92,899 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$16.23 - $20.29 $143,164 - $178,978	-8,821 Reduced 8.67%	92,899 $1.63 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $1.1 Million - $1.88 Million	101,720 New	101,720 $1.77 Million
Q2 2018 Aug 03, 2018	SELL	$9.6 - $14.6 $949,689 - $1.44 Million	-98,926 Closed	0 $0
Q1 2018 Jun 04, 2018	BUY	$5.7 - $12.3 $563,878 - $1.22 Million	98,926 New	98,926 $984,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.7B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.